Premium
Ovarian expression of human insulin‐like growth factor‐I in transgenic mice results in cyst formation
Author(s) -
Dyck Michael K.,
Parlow A.F.,
Sénéchal JeanFrançois,
Sirard MarcAndré,
Pothier François
Publication year - 2001
Publication title -
molecular reproduction and development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.745
H-Index - 105
eISSN - 1098-2795
pISSN - 1040-452X
DOI - 10.1002/mrd.1020
Subject(s) - biology , transgene , endocrinology , medicine , genetically modified mouse , insulin like growth factor , ovary , testosterone (patch) , offspring , ovarian cyst , insulin like growth factor 2 , growth factor , receptor , cyst , gene , genetics , pregnancy , radiology
Abstract Insulin‐like growth factor‐I (IGF‐I) has been implicated in a wide variety of physiological processes including ovarian function. To better understand the ovarian role of IGF‐I, transgenic mice harbouring a human IGF‐I cDNA (hIGF‐I) under the control of the mouse LH receptor promoter were generated. Expression of the hIGF‐I, determined by Northern blot, was found to occur in the gonad tissues of these transgenic mice. The hIGF‐I protein was also detectable by radioimmunoassay in ovarian extracts as well as in the plasma. The fertility of mating transgenic females, as estimated by the number of implantation sites post‐coitum, did not appear to be affected. However, transgenic females who failed to mate and produce offspring were found to possess polycystic ovaries. Evaluation of testosterone, estradiol, and LH levels revealed that transgenic animals had significantly elevated circulating levels of testosterone compared to their non‐transgenic littermates, while LH levels in transgenic females were significantly lower. Yet, estradiol appeared to be unaffected. These results support the contention that the IGF system plays an important role in ovarian function and that an imbalance in this system may result in ovarian pathology. Mol. Reprod. Dev. 59:178–185, 2001. © 2001 Wiley‐Liss, Inc.